Chimeric Antigen Receptor T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma – Latest Data from the ZUMA-1 Study - An Expert Interview with Javier Munoz. Issue 1 (2019) - Munoz, Javier
No abstract available